Previous 10 | Next 10 |
Q2 revenue of $6.0 million, including license revenue Nearly 1,000 prospective MyoPro® candidates with known payers in the patient pipeline Begins to build Medicare Part B patient pipeline following publication of proposed rule by the Centers for Medicare and Medicaid Service...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for th...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that management will be participating in the Maxim...
2023-05-11 18:20:25 ET Myomo, Inc. (MYO) Q1 2023 Results Conference Call May 10, 2023 04:30 PM ET Company Participants Kim Golodetz - Investor Relations, LHA Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Partici...
2023-05-10 16:13:27 ET Myomo press release ( NYSE: MYO ): Q1 GAAP EPS of -$0.11 beats by $0.03 . Revenue of $3.4M (-12.1% Y/Y) beats by $0.06M . For further details see: Myomo GAAP EPS of -$0.11 beats by $0.03, revenue of $3.4M beats by $0.06M
Implementation of virtual waiting room technology enabled a record 438 patients added to the pipeline, up 54% over Q1 2022 Advertising efficiencies resulted in cost per pipeline add of $1,579, down 50% sequentially Conference call begins at 4:30 p.m. Eastern time today ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for th...
2023-04-10 08:55:27 ET Myomo ( NYSE: MYO ) shares added ~7% pre-market Monday after announcing that its joint venture in China has paid $1.7M as the final portion of the initial license fee related to the commercialization of its MyoPro device in that country. Boston, Mass...
Payment of $1.7 million permits the start of activities to manufacture and sell the MyoPro® in China Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suff...
2023-04-03 07:40:14 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! We’ve got an energy stocks rally as well as earnings ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 17:00:05 ET Scott Henry from Industrial Alliance Securities issued a price target of $5.75 for MYO on 2024-07-10 15:33:00. The adjusted price target was set to $5.75. At the time of the announcement, MYO was trading at $4.97. The overall price target consensus...
2024-07-10 16:15:02 ET Alliance Global Partners analyst issues BUY recommendation for MYO on July 10, 2024 03:33PM ET. The previous analyst recommendation was Buy. MYO was trading at $4.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-09 10:30:11 ET Lake Street analyst issues BUY recommendation for MYO on July 9, 2024 08:45AM ET. The previous analyst recommendation was Buy. MYO was trading at $4.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...